Zhihuang Hu

7PUBLICATIONS
16CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 11, 2026
Mutant p53 sensitizes KRAS-driven lung adenocarcinoma to immunotherapy by repressing SPP1.

|Sep 11, 2026
Bevacizumab plus nab-paclitaxel and platinum as second-line therapy for driver-gene-negative non-squamous non-small cell lung cancer after immunochemotherapy: A prospective single-arm single-centre study.

|Aug 27, 2026
Artificial Intelligence-Assisted Prediction of Immunotherapy Benefit and Recurrence Risk Stratification in Gastric Cancer: A Single-Center Real-World Study.

|Oct 02, 2025
BRD9-p53-E2F1 circuit orchestrates cell growth and DNA damage repair in gastric cancer.

Qingqing Zhou, Qi Wang, Yantao Duan

|Mar 27, 2024
Neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: Data from literature review and a real-world analysis.

Yao Zhang, Huiting Li, Bo Yu

|Nov 26, 2022
Plasma Extracellular Vesicle Long RNA in Diagnosis and Prediction in Small Cell Lung Cancer.

Chang Liu, Jinying Chen, Jiatao Liao

Pageof 2

Frequent Collaborators

4 joint publications

Jialei Wang

1 joint publications

Chen-Chen Wang

1 joint publications

Yao Zhang

1 joint publications

Ying Lin